Thyroid hormone replacement one day before 131I therapy in patients
with well-differentiated thyroid cancer

Thyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer

Objective: The current study aimed to determine the efficacy of radioiodine-131 (131I) ablation therapy with thyroid hormone replacement one day before 131I administration in patients with well-differentiated thyroid cancer (DTC). Methods: This retrospective study included 29 patients who underwent...

Full description

Bibliographic Details
Main Authors:	Daiki Kayano, Junichi Taki, Anri Inaki, Hiroshi Wakabayashi, Ayane Nakamura, Makoto Fukuoka, Seigo Kinuya
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2013-04-01
Series:	Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:	thyroid cancer 131I hormone replacement
Online Access:	http://aojnmb.mums.ac.ir/pdf_601_2e15b68287b80394e065006b1c76eecb.html

Similar Items

Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer
by: Hiroshi Wakabayashi, et al.
Published: (2015-01-01)

Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
by: Raita Araki, et al.
Published: (2018-06-01)

Iodine 131 ablation of an obstructive lingual thyroid
by: Lester Johnson, et al.
Published: (2009-01-01)

I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
by: Sato Yuya, et al.
Published: (2012-10-01)

Aplicaciones clínicas del radioyodo 131 (I131) en las enfermedades del tiroides Clinical applications of radioiodine 131 (I131) in the thyroid diseases
by: Levi González Rivero, et al.
Published: (2012-12-01)

Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma
by: JING Zhengjun, et al.
Published: (2022-06-01)

Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01)

Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report
by: Teruaki Sugino, et al.
Published: (2017-12-01)

131I-induced changes in rat thyroid gland function
by: V. Torlak, et al.
Published: (2007-08-01)

Treatment of solitary, autonomously-functioning, non-toxic thyroid nodules with I131 Adenema tiroideo autónomo no tóxico tratamiento con I131
by: Federico Uribe Londoño, et al.
Published: (1991-03-01)

Thyroid Biokinetics for Radioactive I-131 in Twelve Thyroid Cancer Patients via the Refined Nine-Compartmental Model
by: Lung-Fa Pan, et al.
Published: (2022-05-01)

Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
by: Chen Wang, et al.
Published: (2018-12-01)

The Effect of Hypothyroidism on Liver Function in Patients with Differentiated Thyroid Cancer After Operation Before 131I-Treatment
by: ZHANG Hui;DUAN Dong
Published: (2018-02-01)

Thyroid dose assessments due to inhalation of 131I for nuclear medicine workers
by: Gang Liu, et al.
Published: (2022-12-01)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
by: Chae Moon Hong, et al.
Published: (2017-10-01)

Internal exposure levels of thyroid 131I in nuclear medical staff
by: Bin WANG, et al.
Published: (2023-04-01)

Measurement of radiation doses absorbed in the thyroid cancer when treated with radioactive iodine 131I
by: Asema Mahmood Alemam
Published: (2013-06-01)

Mediastinal Images Resembling Thymus Following 131-I Treatment for Thyroid Cancer
by: L. Montella, et al.
Published: (2005-06-01)

Original paper<br>Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue
by: Zbigniew Adamczewski, et al.
Published: (2007-06-01)

Incremental value of post-high dose therapy I-131 scan over pre.therapy diagnostic I-131 scan in patients with differentiated thyroid cancer: Experience from a tertiary care centre in South India
by: Chandra Teja Reddy Singareddy, et al.
Published: (2020-01-01)

Comparison of whole body 131Iodine scan results in four, seven and nine days after radio-iodine therapy of differentiated thyroid cancer
by: Kamran Aryana, et al.
Published: (2019-04-01)

Measurement of Radiation Exposure to Caregivers of Patients with Thyroid Diseases Treated with Iodine-131: A Review
by: Ali Abdulhasan Kadhim, et al.
Published: (2020-09-01)

Correlation between remnant thyroid gland I-131 uptake and serum thyroglobulin levels: can we rely on I-131 whole body scans?
by: Sang Hyun Hwang, et al.
Published: (2024-01-01)

Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis
by: Doina Piciu, et al.
Published: (2023-04-01)

Fiat 131 (typical system shown)
Published: (1977)

Fiat 131 1975-77 autobook/
by: 206830 Ball, Kenneth
Published: (1977)

Cervical lymph node metastasis prediction of postoperative papillary thyroid carcinoma before 131I therapy based on clinical and ultrasound characteristics
by: Fei Yu, et al.
Published: (2023-02-01)

A progress review on methods for in vivo measurement of 131I in thyroids by using portable gamma spectrometers
by: Hongming Liu, et al.
Published: (2021-12-01)

Clinicopathological characteristics and 131I treatment of differentiated thyroid carcinoma in children and adolescents of different age groups
by: QI Mengfang, TIAN Tian, HUANG Rui
Published: (2022-05-01)

Clinical Analysis of the Short-Term Outcome of Papillary Thyroid Micro Carcinoma After 131I Treatment
by: Cao J, et al.
Published: (2021-06-01)

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth
by: Alexandru Mester, et al.
Published: (2021-04-01)

Can we safely reduce the administration of 131-iodine in patients with differentiated thyroid cancer? – experience of the Brugmann hospital in Brussels
by: Laura Iconaru, et al.
Published: (2020-09-01)

FIAT 131 (typical system shown) [carta]
by: Russek, Peter R. D.
Published: (1977)

Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during 131I-meta-iodo-benzyl-guanidine therapy
by: Yuka Taniguchi, et al.
Published: (2022-01-01)

Repair guide Fiat 131/
by: 175551 Russek, Peter R. D.
Published: (1977)

Clinical outcome of 131I therapy in differentiated thyroid cancer patients with suspicious high thyroglobulin concentration
by: GUO Wenting, MU Zhuanzhuan, LI Zheng, ZHANG Yingqiang, JIN Xiaona, LIN Yansong
Published: (2022-05-01)

Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer
by: Haiyan Gao, et al.
Published: (2023-01-01)

Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer
by: Sara Ahmadi, et al.
Published: (2022-05-01)

Advances in Antioxidant Applications for Combating <sup>131</sup>I Side Effects in Thyroid Cancer Treatment
by: Li Yang, et al.
Published: (2023-06-01)

Additive value of 18FDG-PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience
by: Heba M. Abdelhamed, et al.
Published: (2022-01-01)